borderline significancep = 0.05
A subgroup analysis by treatment showed borderline significance between global QoL and mortality risk in both HSCT (HR: 1.05, 95% CI: 1.00–1.11, p = 0.05, I 2 = 0%) and chemotherapy (HR: 1.04, 95% CI: 1.00–1.09, p = 0.05, I 2 = 74%).